-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- PharmaCyte Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was $23.4M.
- PharmaCyte Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was $26.9M.
- PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $334K.
- PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$4.32M, a 1.81% decline from 2021.
- PharmaCyte Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.24M, a 19.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)